{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T17:10:11Z","timestamp":1730826611857,"version":"3.28.0"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Nucl Med"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>\n            Purpose\u2003The biodistribution of gallium-68-dotatate (Ga-68-dotatate) and standardized uptake values (SUVs) using non-time-of-flight (TOF) positron emission tomography\/computed tomography (PET\/CT) cameras is well established. However, with the eventual retirement of older PET cameras and their replacement with newer, highly sensitive TOF PET\/CT cameras, where SUVmax measurements are reportedly higher, updated knowledge of normal SUVmax range is needed and, to our knowledge, not previously reported. Our objectives are as follows:<\/jats:p><jats:p>\n            Methods\u2003Fifty consecutive patients referred routinely to our nuclear medicine service (20 men, 30 women; median age 55 years) with presumed neuroendocrine tumors underwent Ga-68-dotatate scans on a PET-CT camera having capability of reconstructing both TOF\/non-TOF images. Region of interests (ROIs) were drawn around 24 normal structures as well as the primary lesion with abnormal radiotracer uptake and SUVmax was measured. The same ROI was analyzed using both algorithms simultaneously and both TOF and non-TOF SUVmax values were compared.<\/jats:p><jats:p>\n            Results\u2003Twelve hundred ROIs were evaluated. Non-TOF Ga-68-dotatate uptake in normal structures was in alignment with previously published studies. As compared to non-TOF, TOF images had better target to background ratios visually. TOF SUVmax was higher for all structures except for lung and brain. TOF SUVmax was more than double in adrenals\/uncinate process of the pancreas; approximately 1.8 times in abnormal lesions, lymph nodes, pineal gland; and greater than 1.5 times in thyroid, breast, and pancreatic head.<\/jats:p><jats:p>\n            Conclusion\u2003Normal database of Ga-68-dotatate TOF SUVmax is provided for common structures to aid visual detection of abnormalities objectively. Overall, TOF SUVmax measures higher in identical ROIs, with abnormal lesions measuring approximately 1.8 times higher versus non-TOF technology. These findings need to be taken in consideration when comparing patient scans imaged on different PET\/CT technologies.<\/jats:p>","DOI":"10.1055\/s-0044-1786529","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T23:10:29Z","timestamp":1715123429000},"page":"110-118","source":"Crossref","is-referenced-by-count":0,"title":["Time-of-Flight PET\/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging"],"prefix":"10.1055","volume":"23","author":[{"given":"Matthew Clifton","family":"Miller","sequence":"additional","affiliation":[{"name":"School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avani T.","family":"Bansal","sequence":"additional","affiliation":[{"name":"The Potomac School, McLean, Virginia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wingard","sequence":"additional","affiliation":[{"name":"USA Radiology, WRNMMC, Bethesda, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Liza","family":"Lindenberg","sequence":"additional","affiliation":[{"name":"Molecular Imaging Program, NCI, NIH, Washington, DC, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek J.","family":"Stocker","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, WRNMMC, Bethesda, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Adler","sequence":"additional","affiliation":[{"name":"SAIC PET Physicist, Chevy Chase, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpna","family":"Prasad","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, WRNMMC, Bethesda, Maryland, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"A Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/01.pas.0000174013.14569.90","article-title":"Value of immunohistochemistry for somatostatin receptor subtype sst2A in cancer tissues: lessons from the comparison of anti-sst2A antibodies with somatostatin receptor autoradiography","volume":"29","author":"M K\u00f6rner","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2362.2012.02648.x","article-title":"Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer","volume":"42","author":"I Evangelou","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0960-0760(92)90184-K","article-title":"Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications","volume":"43","author":"J C Reubi","year":"1992","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/snuc.2002.31022","article-title":"Somatostatin receptor imaging","volume":"32","author":"D J Kwekkeboom","year":"2002","journal-title":"Semin Nucl Med"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2967\/jnumed.115.163865","article-title":"Safety and efficacy of 68Ga-DOTATATE PET\/CT for diagnosis, staging, and treatment management of neuroendocrine tumors","volume":"57","author":"S A Deppen","year":"2016","journal-title":"J Nucl Med"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2967\/jnumed.115.165803","article-title":"68Ga-dotatate compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis","volume":"57","author":"S A Deppen","year":"2016","journal-title":"J Nucl Med"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-013-0718-4","article-title":"Physiological and tumoral uptake of (68)Ga-DOTATATE: standardized uptake values and challenges in interpretation","volume":"27","author":"S Kuyumcu","year":"2013","journal-title":"Ann Nucl Med"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/RLU.0b013e31825b2555","article-title":"Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET\/CT","volume":"37","author":"J Kunikowska","year":"2012","journal-title":"Clin Nucl Med"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2967\/jnumed.113.126177","article-title":"Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification","volume":"55","author":"I Velikyan","year":"2014","journal-title":"J Nucl Med"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00259-013-2482-z","article-title":"Somatostatin receptor PET\/CT in neuroendocrine tumours: update on systematic review and meta-analysis","volume":"40","author":"H Geijer","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5603\/NMR.2011.0004","article-title":"The diagnostic role of 68Ga-DOTATATE PET\/CT in the detection of neuroendocrine tumours","volume":"14","author":"G \u0141api\u0144ska","year":"2011","journal-title":"Nucl Med Rev Cent East Eur"},{"volume-title":"Nuclear Medicine: Practical Physics, Artifacts, and Pitfalls,","year":"2014","author":"D A Pryma","key":"ref13"},{"volume-title":"NETSPOT. (kit for the preparation of gallium Ga 68 dotatate injection) [package insert]","year":"2016","key":"ref14"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00259-002-1070-4","article-title":"CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET","volume":"30","author":"D Visvikis","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"P E Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MR"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/RLU.0000000000001100","article-title":"Ga-68-DOTATATE uptake in patients with neuroendocrine tumors","volume":"41","author":"F Moradi","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/MNM.0b013e32833f635e","article-title":"Distribution pattern of 68Ga-DOTATATE in disease-free patients","volume":"31","author":"M Shastry","year":"2010","journal-title":"Nucl Med Commun"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"M S Hofman","year":"2015","journal-title":"Radiographics"}],"container-title":["World Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1786529.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:50:11Z","timestamp":1730825411000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1786529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":19,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,6]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1786529","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1450-1147","1607-3312"],"issn-type":[{"type":"print","value":"1450-1147"},{"type":"electronic","value":"1607-3312"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}